Schobel Alexander Mark 4
4 · Aquestive Therapeutics, Inc. · Filed Feb 10, 2021
Insider Transaction Report
Form 4
Schobel Alexander Mark
Chief Innovation/Tech Officer
Transactions
- Sale
Common Stock
2021-02-10$6.75/sh−23,460$158,355→ 837,000 total - Sale
Common Stock
2021-02-09$6.75/sh−11,540$77,895→ 860,460 total
Footnotes (1)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4 on December 16, 2020.